FDA Inspection 1027468 — OneBlood, Inc.

OneBlood, Inc. — FEI 1070214

The FDA completed an inspection of OneBlood, Inc. on August 24, 2017 in Palm Beach Gardens, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Palm Beach Gardens, FL (United States)